Deal Details
New Harbor Completes Continuation Vehicle for LGM Pharma
Summary
New Harbor Capital (“New Harbor” or the “Sponsor”) closed a single asset continuation vehicle (“CV” or the “New Vehicle”) for LGM Pharma, LLC (“LGM Pharma”). The transaction allowed New Harbor to provide a liquidity option to existing fund LPs, simultaneously raise new equity capital and extend the runway to execute several attractive strategic initiatives to drive the continued growth of LGM.
Baird served as exclusive financial advisor to New Harbor on this transaction. The Baird team worked to conduct an efficient and competitive process to achieve the Sponsor’s key objectives.
About
New Harbor is a Chicago-based private equity firm focused on investing in lower middle market, growth-oriented healthcare, education and business services companies. New Harbor’s Partners have over 80 years of combined experience, partnering with strong management teams to systematically enable accelerated growth in value creation. New Harbor is headquartered in Chicago, Illinois.LGM Pharma is a leading contract development and manufacturing organization (CDMO) providing comprehensive Active Pharmaceutical Ingredient (API) sourcing and drug product CDMO solutions to the pharmaceutical, biotechnology and compounding pharmacy industries. LGM Pharma assists clients in managing all phases of the drug product development process, from API sourcing through to commercialization, providing clients a comprehensive one-stop manufacturing solution that reduces risk, increases efficiency and accelerates the path to commercialization. LGM Pharma is headquartered in Boca Raton, Florida.
CONTACT US TO LEARN MORE
- Date
- October 2024
- Company
- New Harbor Capital
- Transaction
- GP Solutions
- Sectors
- Healthcare
- Verticals
-
Pharmaceutical Services
- Target Geography
- North America
Share
